Tag: Overall survival

Browse exclusive Tags!

Selpercatinib Outperforms Competitors in Treating RET-Mutant Thyroid Cancer, France

Discover the promising results of selpercatinib, a kinase inhibitor by Eli Lilly, in treating RET-mutant medullary thyroid cancer. Outperforms competitors with improved outcomes and longer progression-free survival.

High Survival Rates Found in Chinese Breast Cancer Patients Undergoing Breast-Conserving Surgery

Discover the high survival rates found in breast-conserving surgery for Chinese breast cancer patients. Findings emphasize the need for increased implementation for better outcomes.

Popular

High Survival Rates Found in Chinese Breast Cancer Patients Undergoing Breast-Conserving Surgery

Discover the high survival rates found in breast-conserving surgery for Chinese breast cancer patients. Findings emphasize the need for increased implementation for better outcomes.

Subscribe

spot_imgspot_img